Alterations in circulating amino acid metabolite ratio associated with arginase activity are potential indicators of metabolic syndrome: The Korean genome and epidemiology study

Jiyoung Moon, Oh Yoen Kim, Garam Jo, Min-Jeong Shin

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Upregulated arginase activity, which competes with nitric oxide synthase (NOS), impairs nitric oxide production and has been implicated in various metabolic disorders. This study examined whether circulating amino acid metabolite ratios are associated with arginase and NOS activities and whether arginine bioavailability is associated with metabolic syndrome (MetS). Data related to arginase and NOS activities were collected from non-diabetic Koreans without cardiovascular disease (n = 1998) in the Ansan–Ansung cohorts (2005–2006). Subsequently, correlation and multivariate logistic regression analyses were performed. With the increase in the number of MetS risk factors, ratios of circulating amino acid metabolites, such as those of ornithine/citrulline, proline/citrulline, and ornithine/arginine, also significantly increased, whereas arginine bioavailability significantly decreased. These metabolite ratios and arginase bioavailability were also significantly correlated with MetS risk-related parameters, which remained significant after adjusting for covariates. In addition, logistic regression analysis revealed that high ratios of circulating metabolites and low arginine bioavailability, which indicated increased arginase activity, were significantly associated with a high MetS risk. This study demonstrated that altered ratios of circulating amino acid metabolites indicates increased arginase activity and decreased arginine bioavailability, both of which can be potential markers for MetS risk.

Original languageEnglish
Article number740
JournalNutrients
Volume9
Issue number7
DOIs
Publication statusPublished - 2017 Jul 12

Fingerprint

Arginase
arginase
metabolic syndrome
epidemiology
Epidemiology
Biological Availability
arginine
Arginine
bioavailability
Genome
metabolites
Amino Acids
amino acids
genome
nitric oxide synthase
Nitric Oxide Synthase
citrulline
Citrulline
Ornithine
ornithine

Keywords

  • Arginase activity
  • Arginine
  • Bioavailability
  • Citrulline
  • Metabolic syndrome
  • Ornithine
  • Proline

ASJC Scopus subject areas

  • Food Science

Cite this

@article{b0b64a92e48d43aa94b4461e231f2c47,
title = "Alterations in circulating amino acid metabolite ratio associated with arginase activity are potential indicators of metabolic syndrome: The Korean genome and epidemiology study",
abstract = "Upregulated arginase activity, which competes with nitric oxide synthase (NOS), impairs nitric oxide production and has been implicated in various metabolic disorders. This study examined whether circulating amino acid metabolite ratios are associated with arginase and NOS activities and whether arginine bioavailability is associated with metabolic syndrome (MetS). Data related to arginase and NOS activities were collected from non-diabetic Koreans without cardiovascular disease (n = 1998) in the Ansan–Ansung cohorts (2005–2006). Subsequently, correlation and multivariate logistic regression analyses were performed. With the increase in the number of MetS risk factors, ratios of circulating amino acid metabolites, such as those of ornithine/citrulline, proline/citrulline, and ornithine/arginine, also significantly increased, whereas arginine bioavailability significantly decreased. These metabolite ratios and arginase bioavailability were also significantly correlated with MetS risk-related parameters, which remained significant after adjusting for covariates. In addition, logistic regression analysis revealed that high ratios of circulating metabolites and low arginine bioavailability, which indicated increased arginase activity, were significantly associated with a high MetS risk. This study demonstrated that altered ratios of circulating amino acid metabolites indicates increased arginase activity and decreased arginine bioavailability, both of which can be potential markers for MetS risk.",
keywords = "Arginase activity, Arginine, Bioavailability, Citrulline, Metabolic syndrome, Ornithine, Proline",
author = "Jiyoung Moon and Kim, {Oh Yoen} and Garam Jo and Min-Jeong Shin",
year = "2017",
month = "7",
day = "12",
doi = "10.3390/nu9070740",
language = "English",
volume = "9",
journal = "Nutrients",
issn = "2072-6643",
publisher = "Multidisciplinary Digital Publishing Institute (MDPI)",
number = "7",

}

TY - JOUR

T1 - Alterations in circulating amino acid metabolite ratio associated with arginase activity are potential indicators of metabolic syndrome

T2 - The Korean genome and epidemiology study

AU - Moon, Jiyoung

AU - Kim, Oh Yoen

AU - Jo, Garam

AU - Shin, Min-Jeong

PY - 2017/7/12

Y1 - 2017/7/12

N2 - Upregulated arginase activity, which competes with nitric oxide synthase (NOS), impairs nitric oxide production and has been implicated in various metabolic disorders. This study examined whether circulating amino acid metabolite ratios are associated with arginase and NOS activities and whether arginine bioavailability is associated with metabolic syndrome (MetS). Data related to arginase and NOS activities were collected from non-diabetic Koreans without cardiovascular disease (n = 1998) in the Ansan–Ansung cohorts (2005–2006). Subsequently, correlation and multivariate logistic regression analyses were performed. With the increase in the number of MetS risk factors, ratios of circulating amino acid metabolites, such as those of ornithine/citrulline, proline/citrulline, and ornithine/arginine, also significantly increased, whereas arginine bioavailability significantly decreased. These metabolite ratios and arginase bioavailability were also significantly correlated with MetS risk-related parameters, which remained significant after adjusting for covariates. In addition, logistic regression analysis revealed that high ratios of circulating metabolites and low arginine bioavailability, which indicated increased arginase activity, were significantly associated with a high MetS risk. This study demonstrated that altered ratios of circulating amino acid metabolites indicates increased arginase activity and decreased arginine bioavailability, both of which can be potential markers for MetS risk.

AB - Upregulated arginase activity, which competes with nitric oxide synthase (NOS), impairs nitric oxide production and has been implicated in various metabolic disorders. This study examined whether circulating amino acid metabolite ratios are associated with arginase and NOS activities and whether arginine bioavailability is associated with metabolic syndrome (MetS). Data related to arginase and NOS activities were collected from non-diabetic Koreans without cardiovascular disease (n = 1998) in the Ansan–Ansung cohorts (2005–2006). Subsequently, correlation and multivariate logistic regression analyses were performed. With the increase in the number of MetS risk factors, ratios of circulating amino acid metabolites, such as those of ornithine/citrulline, proline/citrulline, and ornithine/arginine, also significantly increased, whereas arginine bioavailability significantly decreased. These metabolite ratios and arginase bioavailability were also significantly correlated with MetS risk-related parameters, which remained significant after adjusting for covariates. In addition, logistic regression analysis revealed that high ratios of circulating metabolites and low arginine bioavailability, which indicated increased arginase activity, were significantly associated with a high MetS risk. This study demonstrated that altered ratios of circulating amino acid metabolites indicates increased arginase activity and decreased arginine bioavailability, both of which can be potential markers for MetS risk.

KW - Arginase activity

KW - Arginine

KW - Bioavailability

KW - Citrulline

KW - Metabolic syndrome

KW - Ornithine

KW - Proline

UR - http://www.scopus.com/inward/record.url?scp=85024114783&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85024114783&partnerID=8YFLogxK

U2 - 10.3390/nu9070740

DO - 10.3390/nu9070740

M3 - Article

C2 - 28704931

AN - SCOPUS:85024114783

VL - 9

JO - Nutrients

JF - Nutrients

SN - 2072-6643

IS - 7

M1 - 740

ER -